Compliance with secondary prevention of ischemic stroke: a prospective evaluation

T Sappok1, A Faulstich, E Stuckert

  • 1Department of Neurology, Stroke Unit, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.

Stroke
|August 4, 2001
PubMed

Insights

Patient compliance with secondary stroke prevention medication is good one year after ischemic stroke. Older age, greater stroke severity, and cardioembolic stroke predict better adherence to antithrombotic and risk factor treatments.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Secondary prevention of ischemic stroke relies on patient adherence to pharmacological therapies.
  • Limited data exist on patient compliance outside clinical trials for antithrombotic and risk factor treatments.
  • Understanding compliance is crucial for effective stroke prevention strategies.

Purpose of the Study:

  • To assess the rate of patient compliance with secondary stroke prevention 1 year after cerebral ischemia.
  • To identify predictors of compliance with antithrombotic and risk factor medications.
  • To determine reasons for noncompliance in stroke patients.

Main Methods:

  • Prospective recruitment of patients with ischemic stroke or TIA on antithrombotic medication.
  • Structured telephone interviews at 1 year to evaluate compliance with antithrombotic and risk factor medications.
  • Logistic regression analysis to identify independent predictors of compliance.

Main Results:

  • At 1 year, 87.6% of patients remained on antithrombotic medication, and 70.2% were on the same agent.
  • Compliance rates for hypertension, diabetes, and hyperlipidemia treatment were 90.8%, 84.9%, and 70.2%, respectively.
  • Older age, higher stroke severity on admission, and cardioembolic stroke cause were significant predictors of compliance.

Conclusions:

  • Compliance with secondary stroke prevention is generally good 1 year post-ischemic stroke in this study cohort.
  • Factors associated with better long-term compliance include advanced age, severe neurological deficits, and cardioembolic stroke etiology.
  • Identifying compliance determinants can guide interventions to enhance stroke prevention quality.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.